Clin2
NCT06900998Possibly a fitNot yet recruiting

Nimodipine study for heavy drinkers

Alcohol Use Disorder

Treatments studied

Part of Mental health clinical trials.

This trial tests if a blood pressure medication called nimodipine can help reduce alcohol drinking in people with moderate to severe alcohol use disorder. You'll take the medication or a placebo and participate in drinking sessions to see how it affects your alcohol intake.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
5 people
Ages
21 years to 50 years
Study type
Interventional

Who can take part

  • You are between 21 and 50 years old.
  • You have been diagnosed with at least moderate alcohol use disorder.
  • You drink between 30 and 70 standard drinks per week if you're a man, or 20 to 65 drinks per week if you're a woman.
  • You are not currently seeking treatment for alcohol or have been in treatment in the past 6 months.
  • You do not have a substance use disorder for drugs other than tobacco or mild cannabis.
  • You are not taking certain medications like other calcium channel blockers or blood pressure drugs.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07681869Not yet recruiting· Phase 2
Can nimodipine help reduce drinking?

This study tests whether a blood pressure medication called nimodipine can help reduce drinking in people with alcohol use disorder. If you are a heavy drinker and not seeking treatment right now, you may be able to join.

New Haven, Connecticut
NCT07520292Recruiting· Phase 1
Testing NTX-2001 to reduce drinking in alcohol use disorder

This study tests whether a new medication called NTX-2001 can help people with alcohol use disorder drink less. Researchers will measure how the drug affects alcohol consumption and safety in adults aged 21–60.

New Haven, Connecticut
NCT04084860Recruiting· Phase 2
Brief medicine trial to help reduce heavy alcohol drinking

This Phase 2 study tests a brief medication approach meant to reduce “problem drinking.” It may help people cut back or stop alcohol use by adjusting brain signaling related to drinking cravings and urges.

New York, New York
NCT05957159Recruiting· Early Phase 1
Testing an alcohol brain imaging study based on opioid receptor balance

This early-phase study looks at how the brain’s opioid receptor balance may be different in people with alcohol use disorder (AUD), using brain scans and blood testing. It may help researchers understand why some people respond differently to alcohol and related treatments.

New Haven, Connecticut
NCT05929677Recruiting· Early Phase 1
Study tests effects on impulsivity and how alcohol feels

This early-phase study looks at how alcohol affects impulsivity (tendency to act quickly) and people’s subjective experiences. You may be able to join if you drink regularly and meet the study safety rules.

Boston, Massachusetts
NCT05827159Recruiting· Phase 3
Medications started in the ER for alcohol use disorder

This study tests whether starting certain medications in the emergency room can help people with moderate to severe alcohol use disorder reduce heavy drinking and withdrawal problems after they leave the ER. It compares outcomes for participants who receive the study medications soon after an ER visit.

New Haven, Connecticut

Hear when a new Alcohol Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.